In a district hospital in rural Chhattisgarh, a technician takes a chest X-ray of a construction worker with a persistent cough. There is no radiologist on site — the nearest one is a three-hour drive away, and the wait for a formal report used to stretch to days. Today, within seconds of the image being captured, an AI algorithm flags a pattern suspicious for tuberculosis and routes the case for urgent follow-up. This is not a pilot project in a research paper; it is daily practice at hundreds of centres across India in 2026. Artificial intelligence has quietly moved from hospital demo rooms into the actual workflow of Indian diagnostics — and it is changing how quickly, and how far, a diagnosis can reach.
For a country where specialist expertise is heavily concentrated in a handful of metro cities, AI-assisted radiology and pathology represent one of the most consequential digital health shifts happening right now. This guide explains, in plain language, what AI diagnostics actually do, where they are already deployed across India, how accurate they are, and what patients should understand — and be cautious about — as these tools become part of routine care.
Why India Needs This Technology
India's diagnostic capacity has a structural mismatch: enormous demand, concentrated supply.
- Radiologist shortage: India has an estimated 20,000–22,000 practising radiologists for a population of over 1.4 billion — roughly one radiologist per 70,000–100,000 people, and the vast majority are concentrated in Tier 1 metro cities. Hospital administrators in Tier 2 and Tier 3 towns routinely report searches of six to eighteen months to fill a single radiologist post
- Pathologist shortage: A similar gap exists in pathology, where trained specialists to read blood smears, biopsy slides, and cytology samples are scarce outside major cities, slowing turnaround for cancer diagnoses in particular
- Volume pressure: India's public health system screens enormous populations for tuberculosis, cervical cancer, and diabetic eye disease every year, far outstripping the number of specialists available to read every image manually
- Rural access gap: A patient in a district hospital or primary health centre often has no realistic way to get a scan reviewed by a sub-specialist within a clinically useful timeframe without travelling to a city
AI-assisted diagnostics do not replace radiologists or pathologists — but they can triage, prioritise, and pre-screen at a scale and speed no human workforce can match, flagging the most urgent cases for a specialist's attention first and extending basic screening capability into places that have never had it.
What AI Diagnostics Actually Do
AI in Radiology (Chest X-rays, CT Scans, Mammography)
The most mature use case in India is chest X-ray interpretation, primarily for tuberculosis, pneumonia, and lung cancer screening. Algorithms trained on millions of annotated X-rays learn to recognise patterns associated with disease and output a probability score or a heat map highlighting the suspicious region.
Qure.ai, a Mumbai-founded company, is India's most widely deployed radiology AI platform, used at over a thousand healthcare centres across the country and integrated into several national TB screening programmes. A 2025 Indian study using AI trained on roughly five million chest X-rays reported around 98% precision and over 95% recall across a range of equipment types and patient demographics for detecting abnormalities including TB, pneumonia, and lung cancer. Under the ICMR-backed India TB Research Consortium, an AI screening tool trained on over 282,000 annotated data points from 54,000 chest X-rays across 18 centres in 11 states was found to increase overall TB case detection by roughly 15.8%, largely by flagging cases that radiologists had not considered presumptive for TB.
Other domestic players such as DeepTek offer similar AI-assisted reporting for X-rays and CT scans, often working directly with diagnostic chains and hospital networks to speed up reporting turnaround.
AI in Pathology (Blood Smears, Biopsy Slides)
Digital pathology converts physical microscope slides into high-resolution digital images that AI software can then analyse. SigTuple, a Bengaluru-based company and one of the earliest players in this space in India, built an integrated hardware-plus-AI platform (branded AI100/Shonit for blood smears) that automates the tedious, error-prone process of manually counting and classifying blood cells under a microscope. It has been deployed in partnership with hospital chains including HealthCare Global (HCG) to support haematopathology labs, including real-world use in flagging leukaemia in areas where trained pathologists are scarce. SigTuple has also received US FDA 510(k) clearance for its digital microscopy platform — a marker of the rigour these systems are increasingly being held to.
AI in Eye Screening (Diabetic Retinopathy)
Diabetic retinopathy — damage to the retina from long-term high blood sugar — is a leading cause of preventable blindness in India's rapidly growing diabetic population. AI algorithms that analyse retinal fundus photographs can flag referable disease with high sensitivity and specificity, and are increasingly used in vision-screening camps and primary care settings where an ophthalmologist is not physically present, referring only the flagged, higher-risk cases onward for a specialist eye exam. If you or a family member has diabetes, our diabetic retinopathy guide explains how often you should be screened.
AI in Cardiology and Stroke
Several Indian hospital networks now use AI to flag suspicious ECG patterns and prioritise CT brain scans that suggest an acute stroke, shaving critical minutes off the "door-to-needle" time for clot-busting treatment — a setting where speed directly affects how much brain tissue is saved.
How Accurate Is AI Diagnostics, Really?
AI performance in Indian studies has generally been strong for the specific, narrow tasks it is trained on — but "accurate" needs context:
| Aspect | What the Evidence Shows |
|---|---|
| Chest X-ray abnormality detection | High precision and recall (often 95%+) in large Indian validation studies, but performance can vary across different X-ray machine brands and patient populations if not properly validated locally |
| TB screening yield | AI-assisted screening has been shown to meaningfully increase case detection compared to radiologist review alone, in ICMR-backed multi-centre studies |
| Diabetic retinopathy screening | Strong sensitivity for detecting referable disease in structured screening settings, though real-world performance can be lower than in controlled trials |
| Rare or atypical presentations | AI trained on common disease patterns can underperform on unusual or rare conditions it has seen little of during training |
The consistent theme across the evidence: AI diagnostics work best as a triage and prioritisation layer, not a replacement for expert review. A flagged "high risk" scan is meant to go to a radiologist faster, and a flagged "low risk" scan is not typically meant to skip specialist review entirely — it simply gets queued appropriately. Regulatory and hospital protocols in India generally still require a qualified radiologist or pathologist to sign off on the final report.
Where You Might Already Be Encountering AI Diagnostics
Most patients don't realise they've already interacted with an AI-assisted diagnosis. It commonly shows up in:
- TB and lung screening camps run by government health programmes or NGOs, especially in high-burden states
- Corporate and community health checkup packages that include chest X-rays or eye screening at scale
- Tertiary and multi-speciality hospital radiology departments, where AI pre-reads scans before a radiologist finalises the report
- Large diagnostic chains (several major pathology and radiology networks have begun integrating AI-assisted reporting to manage volume and speed)
- Diabetes and eye-care clinics offering AI-based retinal screening as part of annual diabetic checkups
Regulation and Ethics: What Governs AI in Indian Healthcare
As AI diagnostics have moved from pilots to production, India has begun building the governance framework around them:
- ICMR's Ethical Guidelines for Application of AI in Biomedical Research and Healthcare (2023) lay out principles covering algorithmic transparency, bias, data handling, informed consent, accountability, and the ethics review process for AI tools used in healthcare and research
- AI-based diagnostic software used clinically in India generally requires medical device clearance, and companies like SigTuple and Qure.ai have pursued international clearances (such as US FDA 510(k)) alongside domestic regulatory pathways, both as a market requirement and a credibility marker
- Human oversight remains the norm: current practice and guidance treat AI outputs as decision support for a licensed doctor, not an autonomous diagnosis — your report should still carry the name and signature of a qualified radiologist or pathologist
- Data privacy for any AI system processing your scans or slides falls under India's Digital Personal Data Protection (DPDP) Act — read our DPDP Act and medical records guide to understand your rights over this data
Questions Worth Asking Your Hospital or Lab
If you learn that AI was involved in reading your scan or sample, reasonable questions to ask include:
- Did a qualified radiologist or pathologist review and sign the final report, or only the AI?
- Was the AI tool validated on an Indian population and on the type of equipment used at this facility?
- What happens if the AI flags something the specialist disagrees with, or vice versa?
- Is there an option for a second opinion if the finding is significant? (See our guide to getting a second medical opinion online)
None of this should feel like an interrogation — most hospitals and diagnostic chains using AI are transparent about it, and are generally happy to explain their quality processes.
The Bigger Picture: AI as an Access Multiplier
The most meaningful impact of AI diagnostics in India isn't in top hospitals that already have excellent specialist access — it's in the district hospitals, primary health centres, and Tier 2/3 towns that previously had none. Government digital health infrastructure, including the Ayushman Bharat Digital Mission (ABDM), is increasingly designed to interoperate with AI-assisted diagnostic tools, aiming to connect screening at the periphery with specialist review at referral centres. Our guide to digital health records in India explains how ABDM and your ABHA ID fit into this bigger interoperability picture.
For individual patients, the practical benefit is faster turnaround and, in underserved areas, access to a level of screening that simply did not exist before. It does not remove the value of a second opinion, a trusted specialist, or your own vigilance about symptoms — but it is quietly making "someone reviewed my scan quickly" a realistic expectation even far from a metro city.
Keeping Track of AI-Assisted Reports
Whether or not AI was involved in generating it, every report you receive — X-ray, biopsy, retinal screening, ECG — should be stored somewhere you can find it later and share it easily with a specialist for review. Uploading your reports to MedicalVault keeps your imaging and pathology reports organised in one place, and MedicalVault's family sharing feature makes it simple to send a report to a relative's doctor or a second-opinion specialist without hunting through old WhatsApp chats or hospital folders.
Key Takeaways
- AI diagnostics are already deployed at scale in India, particularly for chest X-ray/TB screening, diabetic retinopathy screening, and increasingly in pathology and stroke care
- The core driver is India's severe specialist shortage — roughly one radiologist per 70,000–100,000 people, concentrated mostly in metro cities
- Indian studies show strong accuracy for the specific tasks AI is trained on (often 95%+ precision/recall for chest X-ray abnormality detection), but performance depends on proper local validation
- AI is designed to triage and prioritise, not replace, specialist review — a qualified radiologist or pathologist should still sign off on your final report
- ICMR's 2023 ethical guidelines and India's DPDP Act govern how AI tools can use and protect your medical data
- You have every right to ask whether AI was involved in your report and whether a specialist reviewed the findings
- Store all your imaging and pathology reports, AI-assisted or not, in one place with MedicalVault, and always discuss significant findings with your doctor before acting on them